Oncoinvent Announces Positive Final Data from Phase 1/2a Trial of Radspherin® in Patients with Colorectal Peritoneal Metastases ...Middle East

Data demonstrate sustained peritoneal disease control and reinforce the potential of Oncoinvent's novel radiopharmaceutical therapy to target peritoneal disease in colorectal cancer OSLO, Norway, June 18, 2025 /PRNewswire/ -- Oncoinvent ASA, a clinical-stage radiopharmaceutical company...

Hence then, the article about oncoinvent announces positive final data from phase 1 2a trial of radspherin in patients with colorectal peritoneal metastases was published today ( Wednesday 18/06/2025 - 08:46 AM ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Oncoinvent Announces Positive Final Data from Phase 1/2a Trial of Radspherin® in Patients with Colorectal Peritoneal Metastases )

Also on site :

• Five killed in helicopter crash on Africa’s highest mountain (VIDEO)
• transcosmos and V, Inc. launch metaverse creator services for VRChat via Geek Jack, transcosmos's cross-border e-commerce site for entertainment items
• The Christmas Day Storm